These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24260330)

  • 1. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
    Ye J; Li XF; Wang YD; Yuan Y
    PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis.
    Jiang DK; Wang WZ; Ren WH; Yao L; Peng B; Yu L
    J Invest Dermatol; 2011 Jan; 131(1):220-8. PubMed ID: 20861852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
    Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
    Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
    Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
    Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
    Xiang B; Mi YY; Li TF; Liu PF
    Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects.
    Yang X; Yang B; Liu Y; Xu S; Li B
    Indian J Dermatol; 2013 May; 58(3):175-80. PubMed ID: 23723465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
    Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
    Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.
    Zhao Y; Wang F; Shan S; Zhao Y; Qiu X; Li X; Jiao F; Wang J; Du Y
    Int J Med Sci; 2010 Sep; 7(5):300-8. PubMed ID: 20827430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
    Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
    Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
    Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
    Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.
    Carvalho RM; Pinto GR; Yoshioka FK; Lima PD; Souza CR; Guimarães AC; Lamarão LM; Rey JA; Burbano RR
    J Neurooncol; 2012 Oct; 110(1):49-57. PubMed ID: 22886512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations.
    Lao X; Chen Z; Qin A
    Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
    Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
    Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
    Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
    Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population.
    Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD
    Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.